A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
Clinical trial NCT06190093 · COMPLETED
Trial details
- NCT number
- NCT06190093
- Sponsor
- Outlook Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-24
- Primary completion
- 2024-11-07
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.